The primary purpose of any CL care system has always been to protect the eye from potentially harmful microbial agents.

Building up a facility from the ground up has always been a complex process for any doctor.

With individuals spending more time online than in the past, optometrists can use social media sites, such as Facebook and Twitter, to build or grow their practices.

Multi-specialty practices are becoming more commonplace.

The key to treating any disease is to know your enemy before engaging in the battle.

The author describes peoples' and organizations' service to the industry.

Topical bacitracin ointment may be an appropriate, well-tolerated option for treatment of superficial external ocular bacterial infections.

Hybrid contact lens technology has existed for more than 30 years, and with each new wave of advances, its indications and market share have expanded.

Treatment of arterial and venous occlusive diseases often involves consultations with and referrals to ophthalmologists and retina specialists.

Wavefront-optimized and wavefront-guided laser treatments, which may seem new to many patients, now have 5-year track record and are both significant improvements over conventional laser treatments.

Keeping up with developments in ophthalmic therapy could be a full-time job in itself, as new products are constantly tested and introduced, reformulated, given expanded indications, or withdrawn from the market.

Manage the patient's environment, manage the patient systemically, manage inflammation first, and communicate effectively with patients may be considered the new "rule"book for ocular surface disease management.

Analyses of visual acuity results from phase III clinical trials investigating Q.D. bromfenac sodium ophthalmic solution 0.09% for treatment of inflammation and reduction of pain after cataract surgery show treatment with this nonsteroidal anti-inflammatory drug provides functional benefits in addition to its anti-inflammatory and analgesic effects.

The Hudson Valley Optometric Society, a local affiliate of the New York State Optometric Association and the American Optometric Association, has voted to withhold its 2012 AOA dues, placing them in an escrow account until the AOA withdraws support for the American Board of Opometry and its board certification process, a move the organization says it hopes that other societies will follow.

Optometrists here plan to ramp up efforts this fall to secure legislators' support for a bill that would allow them to perform minor surgical techniques and laser procedures, and administer oral glaucoma medications.

Use of nepafenac may decrease macular volume more rapidly after surgery to repair epiretinal membranes.

A new formulation of a fixed antibiotic/corticosteroid combination containing tobramycin and dexamethasone offers several improved characteristics that make it a viable therapeutic option for management of inflammatory ocular conditions where a risk of bacterial ocular infection exists.

A number of topical medications commonly prescribed by optometrists may place the fetus at risk when the patient is pregnant or may be passed on to the infant when the mother is nursing.

TearScience Inc. announced on July 11 that its proprietary thermal pulsation system received FDA clearance for the treatment of meibomian gland dysfunction, also known as evaporative dry eye.

Boost your bottom line by using The Formula, a business method that applies strategy and measures to influence any Key Performance Indicator.